CompletedPhase 2

Combined Ketorolac Bupivacaine Versus Bupivacaine Alone for TAP Block in Children Undergoing Lower Abdominal Surgeries

Egypt90 participantsStarted 2023-06-01

Plain-language summary

Control of of pain in children is fundamental. TAP block is associated with less side effects compared with other neuraxial techniques especially when done under ultrasound guidance. Ketorolac has analgesic effect comparable to morphine. Children were arranged randomly into two equal groups, forty-five children in each. Group (K) (n= 45): received ultrasound guided TAP block with bupivacaine 0.25% (0.5 ml/kg) and ketorolac (0.5 mg/kg). Group (T) (n =45): received ultrasound guided TAP block with bupivacaine 0.25% (0.5 ml/kg)

Who can participate

Age range6 Years – 12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ASA status I and II children Age 6-12 years Elective lower abdominal surgeries. Exclusion Criteria: * Parents' or legal guardians' refusal. * A history of developmental delay or mental retardation. * ASA III and IV. * A known allergy to ketorolac or bupivacaine. * Hemodynamic unstable patient * Urgent surgeries

What they're measuring

1st analgesic requirement

Timeframe: 24 hours

Number of patients who requested analgesia

Timeframe: 24 hours

Trial details

NCT IDNCT06267820

SponsorSohag University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-01

View on ClinicalTrials.gov More Postoperative Pain, Acute trials